Abstract
Sickle cell disease (SCD) and beta-thalassemia are hemoglobinopathies, a group of diseases defined by defects in the structure or synthesis of hemoglobin molecules, respectively. These diseases are considered a global health problem that requires measures to reduce their social and economic burden. Allogeneic hematopoietic stem cell transplantation (AHST) is the only available curative th…